Opioids as modulators of cell death and survival - Unraveling mechanisms and revealing new indications

被引:171
作者
Tegeder, I [1 ]
Geisslinger, G [1 ]
机构
[1] Goethe Univ Frankfurt, Pharmazentrum Frankfurt, Inst Klin Pharmakol, Klinikum Johann Wolfgang Goethe, D-6000 Frankfurt, Germany
关键词
D O I
10.1124/pr.56.3.2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Opioids are powerful analgesics but also drugs of abuse. Because opioid addicts are susceptible to certain infections, opioids have been suspected to suppress the immune response. This was supported by the finding that various immune-competent cells express opioid receptors and undergo apoptosis when treated with opioid alkaloids. Recent evidence suggests that opioids may also effect neuronal survival and proliferation or migrating properties of tumor cells. A multitude of signaling pathways has been suggested to be involved in these extra-analgesic effects of opioids. Growth-promoting effects were found to be mediated through Akt and Erk signaling cascades. Death-promoting effects have been ascribed to inhibition of nuclear factor-kappaB, increase of Fas expression, p53 stabilization, cytokine and chemokine release, and activation of nitric oxide synthase, p38, and c-Jun-N-terminal kinase. Some of the observed effects were inhibited with opioid receptor antagonists or pertussis toxin; others were unaffected. It is still unclear whether these properties are mediated through typical opioid receptor activation and inhibitory G-protein-signaling. The present review tries to unravel controversial findings and provides a hypothesis that may help to integrate diverse results.
引用
收藏
页码:351 / 369
页数:19
相关论文
共 261 条
[1]   Gα13-mediated transformation and apoptosis are permissively dependent on basal ERK activity [J].
Adarichev, VA ;
Vaiskunaite, R ;
Niu, JX ;
Balyasnikova, IV ;
Voyno-Yasenetskaya, TA .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (04) :C922-C934
[2]  
ADAYEV T, 2003, BIOCHIM BIOPHYS ACTA, V7, P85
[3]   Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the ε isozyme of protein kinase C [J].
Aley, KO ;
Messing, RO ;
Mochly-Rosen, D ;
Levine, JD .
JOURNAL OF NEUROSCIENCE, 2000, 20 (12) :4680-4685
[4]   Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H [J].
Alicea, C ;
Belkowski, S ;
Eisenstein, TK ;
Adler, MW ;
Rogers, TJ .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 64 (01) :83-90
[5]  
Alvarez VA, 2002, J NEUROSCI, V22, P5769
[6]   Endomorphins 1 and 2 inhibit IL-10 and IL-12 production and innate immune functions, and potentiate NF-κB DNA binding in THP-1 differentiated to macrophage-like cells [J].
Azuma, Y ;
Ohura, K .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 56 (03) :260-269
[7]  
Barbero S, 2003, CANCER RES, V63, P1969
[8]   Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro [J].
Barbero, S ;
Bajetto, A ;
Bonavia, R ;
Porcile, C ;
Piccioli, P ;
Pirani, P ;
Ravetti, JL ;
Zona, G ;
Spaziante, R ;
Florio, T ;
Schettini, G .
CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS, 2002, 973 :60-69
[9]   Systemic morphine administration suppresses genes involved in antigen presentation [J].
Beagles, K ;
Wellstein, A ;
Bayer, B .
MOLECULAR PHARMACOLOGY, 2004, 65 (02) :437-442
[10]   The fibroblast growth factor receptor is at the site of convergence between μ-opioid receptor and growth factor signaling pathways in rat C6 glioma cells [J].
Belcheva, MM ;
Haas, PD ;
Tan, Y ;
Heaton, VM ;
Coscia, CJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) :909-918